Hazards of percutaneous PFO closure

European Journal of Echocardiography

Volumn 6, Issue 6, 2005, Pages 393-395

  Schwerzmann, Markus ^a   Salehian, Omid ^b  

^a BERN UNIVERSITY HOSPITAL   (Switzerland)

^b MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CLOPIDOGREL;

AIR EMBOLISM; ANTICOAGULATION; ARTERIOVENOUS FISTULA; BLEEDING; BLOOD TRANSFUSION; COLOR ULTRASOUND FLOWMETRY; EDITORIAL; FOLLOW UP; HEART ATRIUM ARRHYTHMIA; HEART ATRIUM SEPTUM DEFECT; HEART TAMPONADE; HEMATOMA; HUMAN; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; LONG TERM CARE; LUNG EMBOLISM; MINIMALLY INVASIVE CARDIAC SURGERY; MORALITY; OPEN HEART SURGERY; OUTCOMES RESEARCH; PERCUTANEOUS CORONARY INTERVENTION; PREVALENCE; PRIORITY JOURNAL; SAFETY; THROMBOGENESIS; THROMBUS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT INDICATION;

CARDIAC SURGICAL PROCEDURES; CARDIAC TAMPONADE; ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; HEART SEPTAL DEFECTS, ATRIAL; HUMANS; PROSTHESES AND IMPLANTS; SURGICAL PROCEDURES, MINIMALLY INVASIVE; THROMBOSIS;

EID: 28244477396     PISSN: 15252167     EISSN: 15322114     Source Type: Journal    
DOI: 10.1016/j.euje.2005.09.007     Document Type: Editorial

References (23)

1. B. Meier PFO closure, when the going gets tough Catheter Cardiovasc Interv 64 2005 345-347
2. T.D. King S.L. Thompson C. Steiner N.L. Mills Secundum atrial septal defect. Nonoperative closure during cardiac catheterization JAMA 235 1976 2506-2509
3. W.J. Rashkind Transcatheter treatment of congenital heart disease Circulation 67 1983 711-716
4. E.B. Sideris S.E. Sideris J.P. Fowlkes R.L. Ehly J.E. Smith R.E. Gulde Transvenous atrial septal defect occlusion in piglets with a "buttoned" double-disk device Circulation 81 1990 312-318
5. U.U. Babic S. Grujicic Z. Djurisic M. Vucinic Transcatheter closure of atrial septal defects Lancet 336 1990 566-567
6. D. Pavcnik K.C. Wright S. Wallace Monodisk: Device for percutaneous transcatheter closure of cardiac septal defects Cardiovasc Intervent Radiol 16 1993 308-312
7. G.S. Das G. Voss G. Jarvis K. Wyche R. Gunther R.F. Wilson Experimental atrial septal defect closure with a new, transcatheter, self-centering device Circulation 88 1993 1754-1764
8. M.J. Sharafuddin X. Gu J.L. Titus M. Urness J.J. Cervera-Ceballos K. Amplatz Transvenous closure of secundum atrial septal defects: preliminary results with a new self-expanding nitinol prosthesis in a swine model Circulation 95 1997 2162-2168
9. N.C. Dobrolet S. Iskowitz L. Lopez R. Whalen E.M. Zahn Sequential implantation of two Helex septal occluder devices in a patient with complex atrial septal anatomy Catheter Cardiovasc Interv 54 2001 242-246
10. N.D. Bridges W. Hellenbrand L. Latson J. Filiano J.W. Newburger J.E. Lock Transcatheter closure of patent foramen ovale after presumed paradoxical embolism Circulation 86 1992 1902-1908
11. P. Khairy C.P. O'Donnell M.J. Landzberg Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli: A systematic review Ann Intern Med 139 2003 753-760
12. C. Varma L.N. Benson M.R. Warr E. Yeo J. Yip C.S. Jaigobin et al. Clinical outcomes of patent foramen ovale closure for paradoxical emboli without echocardiographic guidance Catheter Cardiovasc Interv 62 2004 519-525
13. M. Braun V. Gliech A. Boscheri S. Schoen G. Gahn H. Reichmann et al. Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism: Periprocedural safety and mid-term follow-up results of three different device occluder systems Eur Heart J 25 2004 424-430
14. S. Windecker A. Wahl T. Chatterjee A. Garachemani F.R. Eberli C. Seiler et al. Percutaneous closure of patent foramen ovale in patients with paradoxical embolism: Long-term risk of recurrent thromboembolic events Circulation 101 2000 893-898
15. U. Krumsdorf S. Ostermayer K. Billinger T. Trepels E. Zadan K. Horvath et al. Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1,000 consecutive patients J Am Coll Cardiol 43 2004 302-309
16. H. Anzai J. Child B. Natterson J. Krivokapich M.C. Fishbein V.K. Chan et al. Incidence of thrombus formation on the CardioSEAL and the Amplatzer interatrial closure devices Am J Cardiol 93 2004 426-431
17. R.R. Brandt T. Neumann J. Neuzner M. Rau I. Faude C.W. Hamm Transcatheter closure of atrial septal defect and patent foramen ovale in adult patients using the Amplatzer occlusion device: No evidence for thrombus deposition with antiplatelet agents J Am Soc Echocardiogr 15 2002 1094-1098
18. C. Gaul J.G. Heckmann J. Bremer G. Wasmeier W.J. Huk R. Schrader et al. Thrombus attached to a Sideris septal occluder system 6 years later Dtsch Med Wochenschr 129 2004 87-90
19. FDA Manufacturer and user facility device experience MAUDE database Available from: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/ cfMAUDE/search.cfm 2005
20. A. Divekar T. Gaamangwe N. Shaikh M. Raabe J. Ducas Cardiac perforation after device closure of atrial septal defects with the Amplatzer septal occluder J Am Coll Cardiol 45 2005 1213-1218
21. Z. Amin Z.M. Hijazi J.L. Bass J.P. Cheatham W.E. Hellenbrand C.S. Kleinman Erosion of Amplatzer septal occluder device after closure of secundum atrial septal defects: Review of registry of complications and recommendations to minimize future risk Catheter Cardiovasc Interv 63 2004 496-502
22. T. Trepels H. Zeplin H. Sievert K. Billinger U. Krumsdorf E. Zadan et al. Cardiac perforation following transcatheter PFO closure Catheter Cardiovasc Interv 58 2003 111-113
23. B. Meier J.E. Lock Contemporary management of patent foramen ovale Circulation 107 2003 5-9